Beta-5 Score to evaluate pig islet graft function in a primate pre-clinical model

Xenotransplantation

Volumn 17, Issue 6, 2010, Pages 449-459

  Igarashi, Yasuhiro ^a   D'Hoore, William ^b   Goebbels, Rose Marie ^a   Gianello, Pierre ^a   Dufrane, Denis ^a  

^a UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

encapsulation; follow up; pig islet; pre clinical; primate; xenotransplantation

Indexed keywords

ALGINIC ACID; C PEPTIDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; MANNURONIC ACID; STREPTOZOCIN;

ACCURACY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA 5 SCORE; CELL DENSITY; CELL ENCAPSULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES CONTROL; DIET RESTRICTION; FASTING C PEPTIDE FASTING BLOOD GLUCOSE RATIO; GLUCOSE BLOOD LEVEL; GLUCOSURIA; GRAFT SURVIVAL; HEMOGLOBIN BLOOD LEVEL; INTERNAL CONSISTENCY; MICROENCAPSULATION; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PANCREAS ISLET TRANSPLANTATION; POLYDIPSIA; POLYURIA; POSTPRANDIAL STATE; PRIMATE; PRIORITY JOURNAL; SCORING SYSTEM; STREPTOZOCIN DIABETES; SUITO INDEX; SWINE; VALIDATION PROCESS; XENOTRANSPLANTATION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MACACA FASCICULARIS; MODELS, ANIMAL; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 78650671110     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2010.00612.x     Document Type: Article

References (33)

1. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238.
2. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355: 1318-1330.
3. Cooper DK, Gollackner B, Sachs DH,. Will the pig solve the transplantation backlog? Annu Rev Med 2002; 53: 133-147.
4. Buhler L, Deng S, O'neil J, et al. Adult porcine islet transplantation in baboons treated with conventional immunosuppression or a non-myeloablative regimen and CD154 blockade. Xenotransplantation 2002; 9: 3-13.
5. Hering BJ, Wijkstrom M, Graham ML, et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 2006; 12: 301-303.
6. Cardona K, Korbutt GS, Milas Z, et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 2006; 12: 304-306.
7. Cardona K, Milas Z, Strobert E, et al. Engraftment of adult porcine islet xenografts in diabetic nonhuman primates through targeting of costimulation pathways. Am J Transplant 2007; 7: 2260-2268.
8. Hecht G, Eventov-Friedman S, Rosen C, et al. Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model. Proc Natl Acad Sci U S A 2009; 106: 8659-8664.
9. Van Der Windt DJ, Bottino R, Casu A, et al. Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am J Transplant 2009; 9: 2716-2726.
10. Kenyon NS, Chatzipetrou M, Masetti M, et al. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci U S A 1999; 96: 8132-8137. (Pubitemid 29328420)
11. Hirshberg B, Preston EH, Xu H, et al. Rabbit antithymocyte globulin induction and sirolimus monotherapy supports prolonged islet allograft function in a nonhuman primate islet transplantation model. Transplantation 2003; 76: 55-60.
12. Adams AB, Shirasugi N, Durham MM, et al. Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates. Diabetes 2002; 51: 265-270.
13. Wijkstrom M, Kenyon NS, Kirchhof N, et al. Islet allograft survival in nonhuman primates immunosuppressed with basiliximab, RAD, and FTY720. Transplantation 2004; 77: 827-835.
14. Thomas JM, Contreras JL, Smyth CA, et al. Successful reversal of streptozotocin-induced diabetes with stable allogeneic islet function in a preclinical model of type 1 diabetes. Diabetes 2001; 50: 1227-1236.
15. Contreras JL, Jenkins S, Eckhoff DE, et al. Stable alpha- and beta-islet cell function after tolerance induction to pancreatic islet allografts in diabetic primates. Am J Transplant 2003; 3: 128-138.
16. Rood PP, Bottino R, Balamurugan AN, et al. Reduction of early graft loss after intraportal porcine islet transplantation in monkeys 19. Transplantation 2007; 83: 202-210.
17. Cooper DK, Casu A,. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-chapter 4: pre-clinical efficacy and complication data required to justify a clinical trial. Xenotransplantation 2009; 16: 229-238.
18. Yamada Y, Fukuda K, Fujimoto S, et al. SUIT, secretory units of islets in transplantation: an index for therapeutic management of islet transplanted patients and its application to type 2 diabetes. Diabetes Res Clin Pract 2006; 74: 222-226.
19. Faradji RN, Monroy K, Messinger S, et al. Simple measures to monitor beta-cell mass and assess islet graft dysfunction. Am J Transplant 2007; 7: 303-308.
20. Casu A, Bottino R, Balamurugan AN, et al. Metabolic aspects of pig-to-monkey (Macaca fascicularis) islet transplantation: implications for translation into clinical practice. Diabetologia 2008; 51: 120-129.
21. Dufrane D, Van Steenberghe M, Guiot Y, et al. Streptozotocin-induced diabetes in large animals (pigs/primates): role of GLUT2 transporter and beta-cell plasticity. Transplantation 2006; 81: 36-45.
22. Chalkley HM,. Method for the quantitative morphologic analysis of tissues. J Natl Cancer Inst 1943; 4: 47-53.
23. Dufrane D, Goebbels RM, Saliez A, Guiot Y, Gianello P,. Six-month survival of microencapsulated pig islets and alginate biocompatibility in primates: proof of concept. Transplantation 2006; 81: 1345-1353.
24. Koulmanda M, Qipo A, Chebrolu S, et al. The effect of low versus high dose of streptozotocin in cynomolgus monkeys (Macaca fascilularis). Am J Transplant 2003; 3: 267-272.
25. Theriault BR, Thistlethwaite JR Jr, Levisetti MG, et al. Induction, maintenance, and reversal of streptozotocin-induced insulin-dependent diabetes mellitus in the juvenile cynomolgus monkey (Macaca fascilularis). Transplantation 1999; 68: 331-337.
26. Wijkstrom M, Kirchhof N, Graham M, et al. Cyclosporine toxicity in immunosuppressed streptozotocin-diabetic nonhuman primates. Toxicology 2005; 207: 117-127.
27. Ryan EA, Paty BW, Senior PA, et al. Beta-score: an assessment of beta-cell function after islet transplantation. Diabetes Care 2005; 28: 343-347.
28. Kawai T, Sogawa H, Koulmanda M, et al. Long-term islet allograft function in the absence of chronic immunosuppression: a case report of a nonhuman primate previously made tolerant to a renal allograft from the same donor. Transplantation 2001; 72: 351-354.
29. Koulmanda M, Smith RN, Qipo A, et al. Prolonged survival of allogeneic islets in cynomolgus monkeys after short-term anti-CD154-based therapy: nonimmunologic graft failure? Am J Transplant 2006; 6: 687-696.
30. Thomas FT, Ricordi C, Contreras JL, et al. Reversal of naturally occurring diabetes in primates by unmodified islet xenografts without chronic immunosuppression. Transplantation 1999; 67: 846-854.
31. Sun Y, Ma X, Zhou D, Vacek I, Sun AM,. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest 1996; 98: 1417-1422.
32. Dufrane D, D'hoore W, Goebbels RM, et al. Parameters favouring successful adult pig islet isolations for xenotransplantation in pig-to-primate models. Xenotransplantation 2006; 13: 204-214.
33. Contreras JL, Eckhoff DE, Cartner S, et al. Long-term functional islet mass and metabolic function after xenoislet transplantation in primates. Transplantation 2000; 69: 195-201.